Real-Life Testing of the Prescription Opioid Misuse Index in French Primary Care.
analgesics
general medicine
misuse
pain
primary care
screening
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
11 11 2022
11 11 2022
Historique:
received:
16
09
2022
revised:
08
10
2022
accepted:
26
10
2022
entrez:
26
11
2022
pubmed:
27
11
2022
medline:
30
11
2022
Statut:
epublish
Résumé
Analgesic opioid (AO) misuse by patients ranges from 0% to 50%. General practitioners are the first prescribers of AO. Our objective was to validate the Prescription Opioid Misuse Index (POMI) in primary care. We conducted a psychometric study in patients with chronic pain who had been taking AOs for at least 3 months and were followed in general practice. Patients responded to the POMI at inclusion and after 2 weeks. The reference used was the DSM-V. Sixty-nine GPs included 160 patients (87 women, 54.4%), mean age 56.4 ± 15.2 years. The total POMI score was 1.50 ± 1.27, and 73/160 (45.6.0%) had a score ≥ 2 (misuse threshold). Internal validity was measured with the Kuder-Richardson coefficient, which was 0.44. Correlations between each item and the total score ranged from 0.06 to 0.35. Test-retest reliability was determined from 145 patients: Lin's concordance coefficient was 0.57 [0.46, 0.68]. Correlation with the DSM-V (Spearman's coefficient) was 0.52. The POMI does not have sufficient psychometric properties to be recommended as a tool to identify the misuse of AOs in primary care. This study clearly showed that there is a need to create a monitoring tool specific to primary care.
Identifiants
pubmed: 36429565
pii: ijerph192214845
doi: 10.3390/ijerph192214845
pmc: PMC9690529
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Pain Res. 2016 Jun 28;9:457-67
pubmed: 27418853
Eur J Pain. 2010 Nov;14(10):1014-20
pubmed: 20494598
J Clin Epidemiol. 1993 Dec;46(12):1417-32
pubmed: 8263569
Addict Behav. 2017 Oct;73:133-136
pubmed: 28511097
J Pain. 2009 Feb;10(2):113-30
pubmed: 19187889
Rev Prat. 2010 Dec 20;60(10 Suppl):24-8
pubmed: 22530272
Can J Anaesth. 2022 Aug;69(8):1042-1052
pubmed: 35229249
Rev Med Suisse. 2013 Oct 16;9(402):1917-20
pubmed: 24298716
J Subst Abuse Treat. 2008 Dec;35(4):380-6
pubmed: 18657935
Eur J Pain. 2007 Jul;11(5):490-518
pubmed: 17070082
JAMA. 1995 Aug 23-30;274(8):645-51
pubmed: 7637146
J Clin Epidemiol. 2010 Jul;63(7):737-45
pubmed: 20494804
Eur J Pain. 2006 May;10(4):287-333
pubmed: 16095934
JAMA. 1999 Sep 15;282(11):1061-6
pubmed: 10493205
J Clin Epidemiol. 2007 Jan;60(1):34-42
pubmed: 17161752